Publikationen 2012
- (2012) Immunotherapy of uveal melanoma. Dev Ophthalmol. 2012;49(): 137-49
- (2012) Novel immune modulators used in hematology: impact on NK cells. Front Immunol. 2012;3(): 388
- (2012) Migration of bone marrow-derived cells and improved perfusion after treatment with erythropoietin in a murine model of myocardial infarction. J Cell Mol Med. 2012;16(1): 152-9
- (2012) Antigen-Specific Transfer of Functional Programmed Death Ligand 1 from Human APCs onto CD8+ T Cells via Trogocytosis. J Immunol. 2012;188(2): 744-52
- (2012) Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany. Cancer Immunol Immunother. 2012;61(3): 433-43
- (2012) Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry. Ann Hematol. 2012;91(4): 561-70
- (2012) Survey and analysis of the efficacy and prescription pattern of sorafenib in patients with acute myeloid leukemia. Leuk Lymphoma. 2012;53(6): 1062-7
- (2012) HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines. J Immunol. 2012;188(5): 2136-45
- (2012) High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis. J Mol Med. 2012;90(8): 935-44
- (2012) Influence of NK cell magnetic bead isolation methods on phenotype and function of murine NK cells. J Immunol Methods. 2012;378(1-2): 1-10
- (2012) A recombinant triplebody with specificity for CD19 and HLA-DR mediates ?preferential binding to antigen double-positive cells by dual-targeting. MAbs. 2012;4(1): 45-56
- (2012) Stromal interferon-? signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice. PLoS ONE. 2012;7(3): e34552
- (2012) Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12(5): 383-96
- (2012) HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients. J Immunol Methods. 2012;380(1-2): 40-55
- (2012) Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model. Am J Transplant. 2012;12(7): 1720-9
- (2012) The Interaction of NK Cells and Dendritic Cells in the Tumor Environment: How to Enforce NK Cell & DC Action Under Immunosuppressive Conditions? Curr Med Chem. 2012;19(12): 1771-9
- (2012) Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples. Eur J Haematol. 2012;89(2): 120-7
- (2012) Tumor metabolism as modulator of immune response and tumor progression. Semin Cancer Biol. 2012;22(4): 335-41
- (2012) Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J Antimicrob Chemother. 2012;67(9): 2260-7
- (2012) Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells. Cancer Res. 2012;72(11): 2757-2767
- (2012) Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cells. Stem Cells Dev. 2012;21(17): 3147-51
- (2012) Nuclear HER3 is associated with favorable overall survival in uveal melanoma. Int J Cancer. 2012;130(5): 1120-7
- (2012) Humanized c-Myc Mouse. PLoS ONE. 2012;7(7): e42021
- (2012) Comparative expression profiling of distinct T cell subsets undergoing oxidative stress. PLoS ONE. 2012;7(7): e41345
- (2012) Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells. Oncoimmunology. 2012;1(7): 1200-1201
- (2012) Subtractive hybridization yields a silver resistance determinant unique to nosocomial pathogens in the Enterobacter cloacae complex. J Clin Microbiol. 2012;50(10): 3249-57
- (2012) Prevalences of the Enterobacter cloacae complex and its phylogenetic derivatives in the nosocomial environment. Eur J Clin Microbiol Infect Dis. 2012;31(11): 2951-5
- (2012) Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease. Am J Pathol. 2012;181(5): 1672-80
- (2012) Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease. Blood. 2012;120(14): 2909-17
- (2012) Oral gene application using chitosan-DNA nanoparticles induces transferable tolerance. Clin Vaccine Immunol. 2012;19(11): 1758-64
- (2012) Reduction of transplant arteriosclerosis after treatment with mycophenolate mofetil and ganciclovir in a mouse aortic allograft model. Exp Clin Transplant. 2012;10(6): 592-600
- (2012) Immunoregulatory natural killer cells suppress autoimmunity by down-regulating antigen-specific CD8+ T cells in mice. Endocrinology. 2012;153(9): 4367-79
- (2012) Highlighting Crypt Necrosis by Using Confocal Laser Endomicroscopy for the In Vivo and Real-Time Diagnosis of GI Graft-Versus-Host Disease. J Clin Oncol. 2012;30(35): e368-9
- (2012) SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control. Blood. 2012;120(8): 1691-702
- (2012) Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO. Blood. 2012;120(16): 3246-55
- (2012) Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages. J Immunol. 2012;189(8): 4069-78
- (2012) Moonlighting osteoclasts as undertakers of apoptotic cells. Autoimmunity. 2012;45(8): 612-9
- (2012) [Foreword]. Onkologie. 2012;35 Suppl 2(): 1
- (2012) Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia. 2012;26(9): 2096-102